Filing Flows › Utah Medical Products (UTMD) › Q1 2025
Utah Medical Products (UTMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Utah Medical Products (UTMD) reported revenue of $9.7M for the first quarter 2025 (Q1 2025), -14% from a year earlier and +6% from the quarter before. Operating margin was 32.5%, net earnings $3.0M (31.3% of revenue).
Utah Medical Products, Q1 2025: revenue $9.7M (-14% year over year), operating margin 32.5%, net earnings $3.0M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | +6% | -14% |
| Gross profit | $5.5M | +4% | -18% |
| Operating profit | $3.2M | +8% | -19% |
| Net earnings | $3.0M | +5% | -23% |
| Operating cash flow | $4.5M | +52% | -15% |
| Free cash flow | $4.3M | +46% | -19% |
What changed
Revenue was $9.7M in Q1 2025, down 14% year over year and up 6% from the previous quarter. Gynecology/Electrosurgery/Urology was the largest line at 50% of revenue.
Gross margin was 57.0%, down 2.6 points from a year earlier. Operating profit was $3.2M, a 32.5% margin (down 1.8 points year over year). Operating expenses fell 17% while revenue fell 14%. Net earnings were $3.0M, down 23% year over year. The effective tax rate was 21.2%.
Operating cash flow was $4.5M (down 15% year over year), 147% of net earnings. Non-cash charges added back $709K of depreciation and amortization and $82K of share-based compensation. Working capital and other items added $632K. Capital expenditures of $184K left free cash flow of $4.3M.
Questions
What was Utah Medical Products' revenue in the first quarter 2025?
Utah Medical Products (UTMD) reported revenue of $9.7M for the first quarter 2025 (Q1 2025), -14% from a year earlier and +6% from the quarter before.
Was Utah Medical Products profitable in the first quarter 2025?
Operating profit was $3.2M (32.5% of revenue) and net earnings $3.0M.